EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 1 filers reported holding EDITAS MEDICINE INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $503 | -60.9% | 64,500 | -58.7% | 0.00% | -50.0% |
Q2 2023 | $1,286 | -100.0% | 156,300 | -82.7% | 0.00% | -90.0% |
Q1 2022 | $17,183,000 | +183.7% | 903,400 | +296.1% | 0.02% | +150.0% |
Q4 2021 | $6,056,000 | -23.6% | 228,100 | +62.9% | 0.01% | -20.0% |
Q2 2021 | $7,930,000 | -58.6% | 140,000 | -69.3% | 0.01% | -58.3% |
Q1 2021 | $19,149,000 | +543.2% | 455,927 | +329.7% | 0.02% | +700.0% |
Q3 2020 | $2,977,000 | -49.7% | 106,100 | -47.0% | 0.00% | -40.0% |
Q2 2020 | $5,919,000 | -0.8% | 200,100 | -33.5% | 0.01% | -16.7% |
Q1 2020 | $5,967,000 | +145.5% | 300,900 | +266.5% | 0.01% | +200.0% |
Q4 2019 | $2,431,000 | -73.2% | 82,100 | -77.9% | 0.00% | -75.0% |
Q1 2019 | $9,081,000 | +46.8% | 371,400 | +36.5% | 0.01% | +14.3% |
Q4 2018 | $6,188,000 | -35.2% | 272,000 | -9.4% | 0.01% | -30.0% |
Q3 2018 | $9,549,000 | +451.6% | 300,100 | +133.7% | 0.01% | +233.3% |
Q3 2016 | $1,731,000 | +218.2% | 128,400 | +475.7% | 0.00% | +200.0% |
Q2 2016 | $544,000 | – | 22,304 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. VI, L.L.C. | 4,656,173 | $160,824,000 | 96.46% |
Alphabet Inc. | 256,410 | $8,856,000 | 3.65% |
Casdin Capital, LLC | 85,470 | $2,952,000 | 3.39% |
Wildcat Capital Management, LLC | 247,768 | $8,558,000 | 2.98% |
Omega Fund Management, LLC | 105,007 | $3,627,000 | 2.52% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $59,043,000 | 2.51% |
EcoR1 Capital, LLC | 87,921 | $3,037,000 | 1.06% |
Foresite Capital Management III, LLC | 14,500 | $501,000 | 0.39% |
VIKING GLOBAL INVESTORS LP | 2,135,523 | $73,761,000 | 0.32% |
Schonfeld Strategic Advisors LLC | 9,726 | $336,000 | 0.14% |